Journal article icon

Journal article

Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function

Publication status:
Published
Peer review status:
Reviewed (other)

Actions


Access Document


Authors


Expand authors...
Publisher:
Elsevier Publisher's website
Journal:
Journal of Allergy and Clinical Immunology Journal website
Volume:
143
Issue:
6
Pages:
2329-2333
Publication date:
2019-02-28
Acceptance date:
2019-02-19
DOI:
ISSN:
1097-6825
Pubs id:
pubs:976259
UUID:
uuid:bb84387b-cfa9-49e0-80f1-d8638b3e21c0
Source identifiers:
976259
Local pid:
pubs:976259
Keywords:

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP